The pharmaceutical industry relies heavily on air cargo for fast, safe, and efficient delivery. Animesh Gupta, Regional Account Manager, Manufacturing (Europe & Asia), Goldratt Research Labs USA, shares insights into challenges, improvements, and India’s growing role in global pharmaceutical logistics.
India is poised to lead the way in pharmaceutical logistics via air cargo
Pharmaceutical air cargo is vital for the swift and safe transportation of time-sensitive and temperature-controlled products. This mode of transport offers unmatched speed, consistency, and efficiency, which are essential for the pharmaceutical industry. Airlines follow strict IATA temperature control regulations to maintain product integrity, and in cases where pharmaceutical products are classified as dangerous goods, the IATA Dangerous Goods Regulations ensure additional safety. Certifications such as the Centre of Excellence for Independent Validators in Pharmaceutical Logistics further enhance standards, helping organisations achieve excellence in handling these sensitive shipments.
India’s growing pharma exports
In the post-COVID era, India has solidified its position as a global pharmaceutical leader. With a remarkable 25 percent growth rate, pharmaceutical exports have surged to USD 27 billion. Over 10 percent of this output is exported to the United States, establishing a critical supply chain link between the two nations.
However, logistics costs pose a significant challenge. Globally, logistics expenses for pharmaceuticals average around 7 percent, but India’s costs stand at approximately 12 percent. Lowering this figure to single digits is a recurring discussion point at national forums. Enhancing air cargo efficiency is seen as a key step toward achieving this goal, unlocking significant potential for growth.
Advancements in efficiency
India’s pharmaceutical logistics landscape has witnessed transformative advancements. For instance, the cooling period for shipments, once a lengthy 48 hours, has been drastically reduced with the deployment of advanced X-ray machines. This innovation has expedited cargo movement, ensuring quicker deliveries and improving overall efficiency.
Moreover, the implementation of the Material Safety Data Sheet (MSDS), which provides critical safety information, is now a standard practice. Despite this progress, digitisation remains an area with room for improvement. By streamlining data management, India can address existing challenges, creating a more reliable and efficient logistics system.
Path to sustainability
While air cargo remains indispensable for pharmaceutical logistics, sustainability continues to be a pressing concern. Efforts in digitisation and process optimisation have already reduced delays and inefficiencies, contributing to more sustainable operations.
Nevertheless, there is more to be achieved. India is on the brink of leading the global pharmaceutical supply chain through air cargo, driven by technological innovation, faster processes, and a commitment to sustainability. These advancements will not only strengthen India’s global presence but also align the industry with modern environmental standards.
Looking ahead
The pharmaceutical air cargo industry is poised for significant growth and optimization. With a focus on digitisation, cost reduction, and sustainability, the sector is transforming into a critical pillar of global supply chains. India’s ongoing innovations position it as a future leader in pharmaceutical logistics, ensuring a faster, safer, and greener future for air cargo.
